Changes of nucleolar organizer regions in granulopoietic precursors during the course of chronic myeloid leukemia

被引:13
|
作者
Gilberti, MFP
Metze, K
LorandMetze, I
机构
[1] UNICAMP,HEMOCTR,BR-13081970 CAMPINAS,SP,BRAZIL
[2] STATE UNIV CAMPINAS,FAC MED,DEPT CLIN PATHOL,CAMPINAS,SP,BRAZIL
[3] STATE UNIV CAMPINAS,FAC MED,DEPT PATHOL ANAT,CAMPINAS,SP,BRAZIL
[4] STATE UNIV CAMPINAS,FAC MED,DEPT INTERNAL MED,CAMPINAS,SP,BRAZIL
关键词
nucleolar organizer regions; chronic myeloid leukemia; cytokinetics; myeloproliferative disease;
D O I
10.1007/BF01697979
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study was to analyze the nucleolar organizer region (AgNOR) pattern of granulopoietic precursors in chronic myeloid leukemia (CML) at diagnosis and during the course of the disease. Clusters of AgNORs and isolated dots were counted separately in 24 cases of CML at diagnosis, in 19 cases during the relapse of the chronic phase after treatment, and in 16 cases of blast crisis. For comparison, 20 cases of normal bone marrow were studied. Each cell type had its own characteristic AgNOR pattern, as has been described for normal bone marrow. There was no significant difference in the number of AgNORs between cells in the peripheral blood and bone marrow. Compared with normal granulopoiesis, myeloblasts in CML at diagnosis had lower numbers of clusters, which decreased further during relapse of chronic phase and in blast crisis. Promyelocytes and myelocytes showed significantly fewer dots. The number of AgNOR clusters correlates inversely with the duration of the cell cycle. Therefore, these findings are consistent with the progressive loss in proliferative activity of immature precursors described during the course of CML. As the number of dots indicates cellular maturation, their lower number in promyelocytes and myelocytes in CML favors the concept of a discordant maturation process described in this desease. The separate counting of clusters and dots provides a useful, simple, and cheap method of describing cytokinetic changes during the course of this myeloproliferative disorder.
引用
收藏
页码:275 / 279
页数:5
相关论文
共 50 条
  • [41] Myeloid Sarcoma as a Presentation of Acute Myeloid Leukemia and Blastic Phase in the Course of Chronic Myeloid Leukemia: A Case Report and Literature Review
    Giordano, Ugo
    Sawicki, Mateusz
    Pilch, Justyna
    Mizera, Jakub
    Borkowski, Artur
    Zduniak, Krzysztof
    Dybko, Jaroslaw
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (14)
  • [42] Chronic arsenical poisoning during the treatment of chronic myeloid leukemia
    Kandel, EV
    LeRoy, GV
    ARCHIVES OF INTERNAL MEDICINE, 1937, 60 (05) : 846 - 866
  • [43] Gene mutations in a patient with chronic myelomonocytic leukemia and changes upon progression to acute myeloid leukemia and during treatment
    Jiaming Li
    Sujiang Zhang
    Oncology and Translational Medicine, 2019, 5 (01) : 30 - 32
  • [44] LOW MITOTIC-ACTIVITY OF GRANULOPOIETIC PRECURSOR CELLS IN PH1-CHROMOSOME-NEGATIVE CHRONIC MYELOID LEUKEMIA
    BRANDT, L
    MITELMAN, F
    NILSSON, PG
    SJOGREN, U
    LANCET, 1974, 2 (7882): : 719 - 720
  • [45] Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients
    Klobusická, M
    Kusenda, J
    Babusíková, O
    NEOPLASMA, 2003, 50 (06) : 408 - 415
  • [46] SERUM FERRITIN DURING THE COURSE OF CHRONIC MYELOID-LEUKEMIA - INCREASE OF SERUM FERRITIN AS A MARKER OF DYSERYTHROPOIESIS
    LANG, JM
    EBER, M
    METHLIN, G
    OBERLING, F
    ACTA HAEMATOLOGICA, 1982, 67 (03) : 145 - 149
  • [47] Acute myeloid leukemia and colon carcinoma during the course of acromegaly
    Ozeki, Kazutaka
    Morishita, Yoshihisa
    Saito, Sigeki
    Umemura, Koji
    Yamaguchi, Yohei
    Tatekawa, Shotaro
    Watamoto, Koichi
    Kohno, Akio
    Nogimori, Tsuyoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (05) : 620 - 624
  • [48] Acute myeloid leukemia and colon carcinoma during the course of acromegaly
    Kazutaka Ozeki
    Yoshihisa Morishita
    Sigeki Saito
    Koji Umemura
    Yohei Yamaguchi
    Shotaro Tatekawa
    Koichi Watamoto
    Akio Kohno
    Tsuyoshi Nogimori
    International Journal of Hematology, 2013, 98 : 620 - 624
  • [49] State-of-the-Art Management of Chronic Myeloid Leukemia in the Emerging Regions
    Musteata, Vasile
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S286 - S286
  • [50] PROLONGED REMISSION IN CHRONIC MYELOID LEUKEMIA AFTER A SINGLE COURSE OF MYLERAN
    DJALDETTI, M
    PINKHAS, J
    PADEH, B
    DEVRIES, A
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1965, 1 (4P2): : 827 - +